Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline

被引:539
作者
Landier, W
Bhatia, S
Eshelman, DA
Forte, KJ
Sweeney, T
Hester, AL
Darling, L
Armstrong, ED
Blatt, J
Constine, LS
Freeman, CR
Friedman, DL
Green, DM
Marina, N
Meadows, AT
Neglia, JP
Oeffinger, KC
Robison, LL
Ruccione, KS
Sklar, CA
Hudson, MM
机构
[1] Stanford Univ, Med Ctr, Dept Pediat Hematol Oncol, Stanford, CA 94305 USA
[2] City Hope Comprehens Canc Ctr, Div Pediat, Duarte, CA USA
[3] Univ So Calif, Keck Sch Med, Dept Pediat, Div Hematol Oncol, Los Angeles, CA USA
[4] Childrens Hosp, Los Angeles, CA 90027 USA
[5] Univ Texas, SW Med Sch, Dept Family Practice & Community Med, Dallas, TX 75230 USA
[6] Childrens Med Ctr, Ctr Canc & Blood Disorders, Dallas, TX 75235 USA
[7] Childrens Healthcare Atlanta, Blood Disorders Serv, Atlanta, GA USA
[8] Childrens Healthcare Atlanta, Div Pediat Oncol, AFLAC, Ctr Canc, Atlanta, GA USA
[9] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[10] Patient Advocacy Comm, Childrens Oncol Grp, Lincoln, NE USA
[11] Univ Miami, Sch Med, Dept Pediat, Miami, FL 33152 USA
[12] Univ N Carolina, Div Pediat Hematol Oncol, Chapel Hill, NC USA
[13] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA
[14] Roswell Pk Canc Inst, Dept Pediat, Buffalo, NY 14263 USA
[15] Mem Sloan Kettering Canc Ctr, Dept Pediat Endocrinol, New York, NY 10021 USA
[16] McGill Univ, Dept Radiat Oncol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
[17] Childrens Hosp & Med Ctr, Dept Pediat Hematol Oncol, Seattle, WA 98105 USA
[18] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[19] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA
关键词
D O I
10.1200/JCO.2004.11.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Children's Cincology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers are risk-based, exposure-related clinical practice guidelines intended to promote earlier detection of and intervention for complications that may potentially arise as a result of treatment for pediatric malignancies. Developed through the collaborative efforts of the Children's Oncology Group Late Effects Committee, Nursing Discipline, and Patient Advocacy Committee, these guidelines represent a statement of consensus from a multidisciplinary panel of experts in the late effects of pediatric cancer treatment. The guidelines are both evidence-based (utilizing established associations between therapeutic exposures and late effects to identify high-risk categories) and grounded in the collective clinical experience of experts (matching the magnitude of risk with the intensity of screening recommendations). They are intended for use beginning 2 or more years following the completion of cancer therapy; however, they are not intended to provide guidance for follow-up of the survivor's primary disease. A complementary set of patient education materials ("Health Links") was developed to enhance follow-up care and broaden the application of the guidelines. The information provided in these guidelines is important for health care providers in the fields of pediatrics, oncology, internal medicine, family practice, and gynecology, as well as subspecialists in many fields. Implementation of these guidelines is intended to increase awareness of potential late effects and to standardize and enhance follow-up care provided to survivors of pediatric cancer throughout the lifespan. The Guidelines, and related Health Links, can be downloaded in their entirety at www.survivorshipguidelines.org.
引用
收藏
页码:4979 / 4990
页数:12
相关论文
共 59 条
[21]   The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease [J].
Fein, DA ;
Hanlon, AL ;
Corn, BW ;
Curran, WJ ;
Coia, LR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (01) :13-18
[22]  
FLEMING ID, 1985, CANCER-AM CANCER SOC, V55, P1190, DOI 10.1002/1097-0142(19850315)55:6<1190::AID-CNCR2820550609>3.0.CO
[23]  
2-6
[24]  
GARRE ML, 1994, AM J PEDIAT HEMATOL, V16, P143
[25]   Current perspectives on radiation-induced breast cancer [J].
Goss, PE ;
Sierra, S .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :338-347
[26]   THYROID-FUNCTION IN PEDIATRIC-PATIENTS AFTER NECK IRRADIATION FOR HODGKIN DISEASE [J].
GREEN, DM ;
BRECHER, ML ;
YAKAR, D ;
BLUMENSON, LE ;
LINDSAY, AN ;
VOORHESS, ML ;
MACGILLIVRAY, M ;
FREEMAN, AI .
MEDICAL AND PEDIATRIC ONCOLOGY, 1980, 8 (02) :127-136
[27]   BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE [J].
HANCOCK, SL ;
TUCKER, MA ;
HOPPE, RT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (01) :25-31
[28]   THYROID-DISEASES AFTER TREATMENT OF HODGKINS-DISEASE [J].
HANCOCK, SL ;
COX, RS ;
MCDOUGALL, IR .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (09) :599-605
[29]   Increased mortality after successful treatment for Hodgkin's disease [J].
Hudson, MM ;
Poquette, CA ;
Lee, J ;
Greenwald, CA ;
Shah, A ;
Luo, XL ;
Thompson, EI ;
Wilimas, JA ;
Kun, LE ;
Crist, WM .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3592-3600
[30]   Late mortality of long-term survivors of childhood cancer [J].
Hudson, MM ;
Jones, D ;
Boyett, J ;
Sharp, GB ;
Pui, CH .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2205-2213